Markus Granlund Becomes Permanent CEO of TFS HealthScience
Company - People | Jun 25, 2025 | Ratos
Markus Granlund, who had been serving as the interim CEO of TFS HealthScience since February 2025, has been officially appointed as the permanent CEO. During his interim tenure, Granlund demonstrated effective leadership and strategic vision, which has been integral to TFS's development as a global contract research organization (CRO). TFS HealthScience, a global CRO, partners with biotechnology and pharmaceutical companies to advance treatments and improve patient outcomes. With operations in 50 countries, it specializes in dermatology, internal medicine, neuroscience, oncology, and ophthalmology, providing flexible solutions through strategic partnerships. Ratos, a Swedish publicly listed business group, wholly owns TFS HealthScience. The group consists of 14 companies across three business areas: Construction & Services, Industry, and Consumer, predominantly operating in the Nordic region with headquarters in Stockholm, Sweden. Granlund is eager to continue with TFS, focusing on leveraging newly aligned corporate structures to deliver greater value to clients, emphasizing impactful science and meaningful partnerships.
Sectors
- Contract Research Organizations (CRO)
- Biotechnology and Pharmaceuticals
- Private Equity
Geography
- Sweden – Ratos, the parent company of TFS HealthScience, is headquartered in Stockholm, Sweden, and plays a major role in the management and direction of TFS.
- Global – TFS HealthScience operates in over 50 countries, making it a globally relevant company in the CRO industry.
- Nordic Region – Ratos operates predominantly in the Nordic region, which is a focus area of their business strategy.
Industry
- Contract Research Organizations (CRO) – The article discusses the role of TFS HealthScience as a global CRO, partnering with biotechnology and pharmaceutical companies for drug development and clinical research services.
- Biotechnology and Pharmaceuticals – TFS HealthScience operates in this industry by providing research and development services to biotechnology and pharmaceutical firms.
- Private Equity – Ratos, a private equity firm, owns TFS HealthScience, hence the operations and management changes discussed fall under private equity activities.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Markus Granlund | Permanent CEO | People | Recently appointed as the permanent CEO of TFS HealthScience. He was previously the interim CEO. |
| TFS HealthScience | Target Company | Company | A global Contract Research Organization offering clinical research and strategic resourcing services. |
| Ratos | Owner | Company | A Swedish-based private equity business group, which wholly owns TFS HealthScience. |
| Katarina Ageborg | Chairman of the Board of Directors | People | Chairman of TFS HealthScience's Board of Directors since February 2025. |